These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2999259)

  • 1. Glycoproteins of human parainfluenza virus type 3: characterization and evaluation as a subunit vaccine.
    Ray R; Brown VE; Compans RW
    J Infect Dis; 1985 Dec; 152(6):1219-30. PubMed ID: 2999259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal immunization of hamsters with envelope glycoproteins of human parainfluenza virus type 3.
    Ray R; Glaze BJ; Moldoveanu Z; Compans RW
    J Infect Dis; 1988 Apr; 157(4):648-54. PubMed ID: 2831281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters.
    Rydbeck R; Löve A; Norrby E
    J Gen Virol; 1988 May; 69 ( Pt 5)():1019-24. PubMed ID: 2836547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response.
    Ray R; Glaze BJ; Compans RW
    J Virol; 1988 Mar; 62(3):783-7. PubMed ID: 2828674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human parainfluenza virus induces a type-specific protective immune response.
    Ray R; Matsuoka Y; Burnett TL; Glaze BJ; Compans RW
    J Infect Dis; 1990 Sep; 162(3):746-9. PubMed ID: 2167342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the replication and immunogenicity of recombinant human parainfluenza virus type 3 vectors expressing up to three foreign glycoproteins.
    Skiadopoulos MH; Surman SR; Riggs JM; Orvell C; Collins PL; Murphy BR
    Virology; 2002 May; 297(1):136-52. PubMed ID: 12083844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycoproteins of human parainfluenza virus type 3: affinity purification, antigenic characterization and reconstitution into lipid vesicles.
    Ray R; Compans RW
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():409-18. PubMed ID: 3029283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the immunogenicity and protective efficacy of a candidate parainfluenza virus type 3 subunit vaccine in cotton rats.
    Ambrose MW; Wyde PR; Ewasyshyn M; Bonneau AM; Caplan B; Meyer HL; Klein M
    Vaccine; 1991 Jul; 9(7):505-11. PubMed ID: 1654680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children.
    Kasel JA; Frank AL; Keitel WA; Taber LH; Glezen WP
    J Virol; 1984 Dec; 52(3):828-32. PubMed ID: 6092715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of bovine parainfluenza virus type 3 in nonhuman primates and its ability to confer immunity to human parainfluenza virus type 3 challenge.
    van Wyke Coelingh KL; Winter CC; Tierney EL; London WT; Murphy BR
    J Infect Dis; 1988 Apr; 157(4):655-62. PubMed ID: 2831282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody responses of humans and nonhuman primates to individual antigenic sites of the hemagglutinin-neuraminidase and fusion glycoproteins after primary infection or reinfection with parainfluenza type 3 virus.
    van Wyke Coelingh KL; Winter CC; Tierney EL; Hall SL; London WT; Kim HW; Chanock RM; Murphy BR
    J Virol; 1990 Aug; 64(8):3833-43. PubMed ID: 1695256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins.
    Heminway BR; Yu Y; Galinski MS
    Virus Res; 1994 Jan; 31(1):1-16. PubMed ID: 8165862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses.
    Ray R; Compans RW
    Virology; 1986 Jan; 148(1):232-6. PubMed ID: 2417412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microencapsulated human parainfluenza virus induces a protective immune response.
    Ray R; Novak M; Duncan JD; Matsuoka Y; Compans RW
    J Infect Dis; 1993 Mar; 167(3):752-5. PubMed ID: 8382726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.
    Spriggs MK; Murphy BR; Prince GA; Olmsted RA; Collins PL
    J Virol; 1987 Nov; 61(11):3416-23. PubMed ID: 2822951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to PIV3.
    Tao T; Davoodi F; Cho CJ; Skiadopoulos MH; Durbin AP; Collins PL; Murphy BR
    Vaccine; 2000 Jan; 18(14):1359-66. PubMed ID: 10618533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with vaccinia virus recombinants that express the surface glycoproteins of human parainfluenza virus type 3 (PIV3) protects patas monkeys against PIV3 infection.
    Spriggs MK; Collins PL; Tierney E; London WT; Murphy BR
    J Virol; 1988 Apr; 62(4):1293-6. PubMed ID: 2831389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A live attenuated chimeric recombinant parainfluenza virus (PIV) encoding the internal proteins of PIV type 3 and the surface glycoproteins of PIV type 1 induces complete resistance to PIV1 challenge and partial resistance to PIV3 challenge.
    Tao T; Skiadopoulos MH; Durbin AP; Davoodi F; Collins PL; Murphy BR
    Vaccine; 1999 Mar; 17(9-10):1100-8. PubMed ID: 10195620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus.
    van Wyke Coelingh KL; Murphy BR; Collins PL; Lebacq-Verheyden AM; Battey JF
    Virology; 1987 Oct; 160(2):465-72. PubMed ID: 2821684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.